Verrica Pharmaceuticals Inc.(VRCA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VRCA Verrica Pharmaceuticals Inc.

盘前交易 11-13 06:37:04 EST

3.72

-0.19

-4.86%

盘前4.29

+0.57+15.32%

04:37 EST

最高4.21	最低3.72	成交量10.58万
今开3.94	昨收3.91	日振幅12.53%
总市值6,391万	流通市值2,521万	总股本1,718万
成交额42.20万	换手率1.56%	流通股本677.74万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VRCA","market":"US","secType":"STK","nameCN":"Verrica Pharmaceuticals Inc.","latestPrice":3.72,"timestamp":1794517200000,"preClose":3.91,"halted":0,"volume":105817,"hourTrading":{"tag":"盘前","latestPrice":4.29,"preClose":3.72,"latestTime":"04:37 EST","volume":57,"amount":231.57999900000002,"timestamp":1794562629261,"change":0.57,"changeRate":0.153226,"amplitude":0.094086},"delay":0,"changeRate":-0.048593350383631696,"floatShares":6777400,"shares":17178800,"eps":-1.74,"marketStatus":"盘前交易","change":-0.19,"latestTime":"11-13 06:37:04 EST","open":3.94,"high":4.21,"low":3.72,"amount":421997.9632026,"amplitude":0.12532,"askPrice":4.19,"askSize":60,"bidPrice":1.5,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.74,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794580200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1529035200000,"exchange":"NASDAQ","adjPreClose":3.72,"preHourTrading":{"tag":"盘前","latestPrice":4.29,"preClose":3.72,"latestTime":"04:37 EST","volume":57,"amount":231.57999900000002,"timestamp":1794562629261,"change":0.57,"changeRate":0.153226,"amplitude":0.094086},"postHourTrading":{"tag":"盘后","latestPrice":3.71,"preClose":3.72,"latestTime":"19:32 EST","volume":204,"amount":758.41,"timestamp":1794529932978,"change":-0.01,"changeRate":-0.002688,"amplitude":0},"volumeRatio":1.2473919075005653,"impliedVol":3.0461,"impliedVolPercentile":0.78},"requestUrl":"/m/hq/s/VRCA/tweets","defaultTab":"tweets","newsList":[{"id":"1134510626","title":"Verrica Pharmaceuticals完成Ycanth®治疗寻常疣的首个关键性III期试验（Cove-2）入组，顶线数据预计2027年第一季度公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1134510626","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134510626?lang=zh_cn&edition=full","pubTime":"2026-08-27 20:01","pubTimestamp":1787832070,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals宣布，其评估Ycanth用于治疗寻常疣的首个关键性III期临床试验已圆满完成患者入组。公司预计，该试验的顶线数据将在2027年第一季度对外公布。这一里程碑标志着Verrica Pharmaceuticals在推进Ycanth治疗常见皮肤疾病方面迈出了关键一步。业界普遍关注这项试验的最终结果，因为它不仅关系到Ycanth的监管审批前景，更可能为寻常疣患者带来新的治疗选择。Verrica Pharmaceuticals对这一进展表示乐观，并将持续致力于为患者提供创新疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101200146","title":"Verrica Pharmaceuticals 获得最高2750万美元非稀释性信贷额度，助力增长战略","url":"https://stock-news.laohu8.com/highlight/detail?id=1101200146","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101200146?lang=zh_cn&edition=full","pubTime":"2026-08-07 04:02","pubTimestamp":1786046539,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc.（股票代码：VRCA）近日宣布，其已成功完成一笔最高达2750万美元的信贷融资安排。这笔资金被定位为非稀释性的增长资本，意味着公司无需通过发行新股来获取资金，从而避免了对现有股东权益的摊薄。此举为公司的长远发展注入了强劲的财务动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115517449","title":"Verrica Pharmaceuticals 将于2026年8月6日披露第二季度财报并发布公司最新动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1115517449","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115517449?lang=zh_cn&edition=full","pubTime":"2026-07-30 20:01","pubTimestamp":1785412886,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc.（股票代码：VRCA）宣布，计划于2026年8月6日公布其第二季度财务业绩，并同步向市场提供公司业务的最新进展信息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179168629","title":"Verrica制药公司：将获得Medomie在以色列销售产品净售价的60%","url":"https://stock-news.laohu8.com/highlight/detail?id=1179168629","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179168629?lang=zh_cn&edition=full","pubTime":"2026-07-21 20:07","pubTimestamp":1784635622,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. 宣布，公司将获得其合作伙伴Medomie在以色列市场所销售相关产品的净售价的60%。此项协议明确了双方在特定区域内的收益分配机制。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151669648","title":"Verrica Pharmaceuticals Inc. 有资格获得总计高达820万美元的监管与商业里程碑款项","url":"https://stock-news.laohu8.com/highlight/detail?id=1151669648","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151669648?lang=zh_cn&edition=full","pubTime":"2026-07-21 20:03","pubTimestamp":1784635413,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. 已符合条件，可获取总计高达820万美元的监管及商业里程碑付款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165758477","title":"Verrica制药与Medomie Pharma达成独家分销、营销与供应协议，在以色列商业化Ycanth®用于治疗传染性软疣","url":"https://stock-news.laohu8.com/highlight/detail?id=1165758477","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165758477?lang=zh_cn&edition=full","pubTime":"2026-07-21 20:01","pubTimestamp":1784635300,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. 与 Medomie Pharma已签署一项独家分销、营销及供应协议，旨在以色列市场推出Ycanth®，用于治疗传染性软疣。该协议授权Medomie Pharma在以色列境内独家负责Ycanth®的商业化活动，包括分销、市场推广及供应链管理。Ycanth®是Verrica公司开发的一款针对传染性软疣的处方疗法。此次合作旨在扩大该疗法在中东地区的可及性，满足当地患者的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164626689","title":"Verrica制药授予Medomie在以色列独家获取及维持Ycanth营销授权的权利","url":"https://stock-news.laohu8.com/highlight/detail?id=1164626689","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164626689?lang=zh_cn&edition=full","pubTime":"2026-07-21 20:01","pubTimestamp":1784635300,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. 已授予Medomie公司在以色列独家获取并维持其产品Ycanth营销授权的权利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180761833","title":"Verrica Pharmaceuticals宣布其3期项目评估Ycanth®治疗寻常疣的第二项关键临床试验首位美国患者开始给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1180761833","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180761833?lang=zh_cn&edition=full","pubTime":"2026-06-22 20:08","pubTimestamp":1782130131,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. (VRCA) 宣布，其针对Ycanth® (Vp-102) 治疗寻常疣的3期项目中的第二项关键临床试验（Cove-3）已为首位美国患者完成首次给药。这一进展标志着该公司在推进该潜在疗法用于治疗这一常见皮肤病的临床开发进程中迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518227291","title":"Verrica制药盘中异动 临近午盘快速拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518227291?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:46","pubTimestamp":1741621565,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时46分，Verrica制药股票出现异动，股价急速上涨5.30%。截至发稿，该股报0.640美元/股，成交量13.9209万股，换手率0.15%，振幅7.71%。Verrica制药股票所在的生物技术行业中，整体涨幅为0.14%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023460696405344&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023460696405344&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516677013","title":"Verrica制药盘中异动 早盘股价大跌7.44%报0.593美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516677013?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:46","pubTimestamp":1741099583,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时46分，Verrica制药股票出现波动，股价快速下跌7.44%。截至发稿，该股报0.593美元/股，成交量9.0819万股，换手率0.10%，振幅11.19%。机构评级方面，在所有5家参与评级的机构中，40%的券商给予买入建议，60%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体涨幅为0.36%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224623989bb086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224623989bb086&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514378122","title":"Verrica制药盘中异动 早盘股价大涨5.07%报0.620美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514378122?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753116,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Verrica制药股票出现异动，股价大幅上涨5.07%。截至发稿，该股报0.620美元/股，成交量7287股，换手率0.01%，振幅0.00%。机构评级方面，在所有4家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体涨幅为0.02%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223156989679bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223156989679bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRPX","BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514380226","title":"Verrica制药盘中异动 股价大跌6.70%报0.662美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514380226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514380226?lang=zh_cn&edition=full","pubTime":"2025-02-28 01:01","pubTimestamp":1740675685,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日01时01分，Verrica制药股票出现异动，股价急速下跌6.70%。截至发稿，该股报0.662美元/股，成交量12.3952万股，换手率0.14%，振幅6.39%。机构评级方面，在所有5家参与评级的机构中，40%的券商给予买入建议，60%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体涨幅为0.40%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228010126abdf91c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228010126abdf91c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514685274","title":"Verrica制药盘中异动 快速拉升6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514685274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514685274?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:06","pubTimestamp":1740585987,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时06分，Verrica制药股票出现波动，股价急速拉升6.04%。截至发稿，该股报0.720美元/股，成交量4.6793万股，换手率0.05%，振幅4.71%。Verrica制药股票所在的生物技术行业中，整体涨幅为0.19%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270006279631619d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270006279631619d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514726687","title":"Verrica制药盘中异动 大幅下跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514726687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514726687?lang=zh_cn&edition=full","pubTime":"2025-02-25 02:16","pubTimestamp":1740421006,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日02时16分，Verrica制药股票出现异动，股价急速下挫5.27%。截至发稿，该股报0.697美元/股，成交量11.4309万股，换手率0.13%，振幅8.68%。Verrica制药股票所在的生物技术行业中，整体跌幅为0.37%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225021646962ec798&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225021646962ec798&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512481564","title":"Verrica制药盘中异动 急速下跌6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512481564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512481564?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:52","pubTimestamp":1739980334,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时52分，Verrica制药股票出现异动，股价大幅下挫6.04%。截至发稿，该股报0.689美元/股，成交量10.3381万股，换手率0.11%，振幅8.64%。机构评级方面，在所有5家参与评级的机构中，40%的券商给予买入建议，60%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体涨幅为0.55%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219235214988b3e3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219235214988b3e3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512657141","title":"Verrica制药盘中异动 早盘急速拉升5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512657141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512657141?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:42","pubTimestamp":1739889748,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时42分，Verrica制药股票出现异动，股价急速上涨5.85%。截至发稿，该股报0.780美元/股，成交量3.1254万股，换手率0.03%，振幅2.50%。机构评级方面，在所有5家参与评级的机构中，40%的券商给予买入建议，60%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体涨幅为0.55%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182242289889ff3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182242289889ff3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRCA","PULM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511567691","title":"Verrica制药盘中异动 早盘股价大涨6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511567691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511567691?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:54","pubTimestamp":1739544882,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时54分，Verrica制药股票出现异动，股价急速上涨6.17%。截至发稿，该股报0.692美元/股，成交量1.2461万股，换手率0.01%，振幅4.07%。Verrica制药股票所在的生物技术行业中，整体涨幅为0.25%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214225443abcf0be4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214225443abcf0be4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRCA","VRPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509827152","title":"Verrica制药盘中异动 急速上涨6.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509827152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509827152?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:31","pubTimestamp":1738765866,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时31分，Verrica制药股票出现异动，股价快速上涨6.37%。截至发稿，该股报0.710美元/股，成交量1.0558万股，换手率0.01%，振幅0.00%。Verrica制药股票所在的生物技术行业中，整体涨幅为0.80%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223106abc37d39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223106abc37d39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VRCA","KTTA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509499110","title":"Verrica制药盘中异动 临近收盘股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509499110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509499110?lang=zh_cn&edition=full","pubTime":"2025-02-05 04:37","pubTimestamp":1738701472,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日04时37分，Verrica制药股票出现异动，股价大幅拉升5.18%。截至发稿，该股报0.674美元/股，成交量16.6899万股，换手率0.18%，振幅7.50%。Verrica制药股票所在的生物技术行业中，整体涨幅为1.40%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205043752a2396c51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205043752a2396c51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508996132","title":"Verrica制药盘中异动 下午盘股价大跌5.19%报0.680美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508996132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508996132?lang=zh_cn&edition=full","pubTime":"2025-02-01 02:35","pubTimestamp":1738348504,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日02时35分，Verrica制药股票出现异动，股价大幅跳水5.19%。截至发稿，该股报0.680美元/股，成交量4.8255万股，换手率0.05%，振幅7.50%。Verrica制药股票所在的生物技术行业中，整体涨幅为0.98%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201023504a2356c7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201023504a2356c7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.verrica.com","stockEarnings":[{"period":"1week","weight":0.2039},{"period":"1month","weight":0.0391},{"period":"3month","weight":-0.2515},{"period":"6month","weight":-0.4067},{"period":"1year","weight":-0.0262},{"period":"ytd","weight":-0.5523}],"compareEarnings":[{"period":"1week","weight":0.0329},{"period":"1month","weight":-0.0269},{"period":"3month","weight":-0.0248},{"period":"6month","weight":0.0243},{"period":"1year","weight":0.1079},{"period":"ytd","weight":0.1103}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Verrica Pharmaceuticals Inc.于2013年7月3日根据特拉华州法律注册成立。该公司是一家开发和商业化用于皮肤病（包括皮肤癌）的临床施用治疗药物的公司。其商业化产品YCANTH已获批用于治疗传染性软疣，研发管线中还包括针对寻常疣和基底细胞癌的候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.064974},{"month":2,"riseRate":0.5,"avgChangeRate":0.04305},{"month":3,"riseRate":0.25,"avgChangeRate":-0.05513},{"month":4,"riseRate":0.5,"avgChangeRate":0.011304},{"month":5,"riseRate":0.25,"avgChangeRate":-0.134822},{"month":6,"riseRate":0.625,"avgChangeRate":0.074464},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.005586},{"month":8,"riseRate":0.555556,"avgChangeRate":-0.03459},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.084968},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.111713},{"month":11,"riseRate":0.555556,"avgChangeRate":0.214596},{"month":12,"riseRate":0.375,"avgChangeRate":0.021484}],"exchange":"NASDAQ","name":"Verrica Pharmaceuticals Inc.","nameEN":"Verrica Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Verrica Pharmaceuticals Inc.(VRCA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Verrica Pharmaceuticals Inc.(VRCA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Verrica Pharmaceuticals Inc.,VRCA,Verrica Pharmaceuticals Inc.股票,Verrica Pharmaceuticals Inc.股票老虎,Verrica Pharmaceuticals Inc.股票老虎国际,Verrica Pharmaceuticals Inc.行情,Verrica Pharmaceuticals Inc.股票行情,Verrica Pharmaceuticals Inc.股价,Verrica Pharmaceuticals Inc.股市,Verrica Pharmaceuticals Inc.股票价格,Verrica Pharmaceuticals Inc.股票交易,Verrica Pharmaceuticals Inc.股票购买,Verrica Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Verrica Pharmaceuticals Inc.(VRCA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Verrica Pharmaceuticals Inc.(VRCA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}